StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSL Limited
ASX:CSL.AX
Sector
Location
Market Cap
USD 81.05 B
Share Price
USD 167.39
Avg Daily Volume
834,388
Change (1 day)
3.87%
Change (1 year)
-19.77%
Change (YTD)
-3.95%
CSL Limited Net Income for the year ending June 30, 2024: USD 2.64 B
CSL Limited Net Income is USD 2.64 B for the year ending June 30, 2024, a -20.81% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
-
CSL Limited Net Income for the year ending June 30, 2023 was USD 3.34 B, a 7.30% change year over year.
-
CSL Limited Net Income for the year ending June 30, 2022 was USD 3.11 B, a 30.07% change year over year.
-
CSL Limited Net Income for the year ending June 30, 2021 was USD 2.39 B, a 10.00% change year over year.
-
CSL Limited Net Income for the year ending June 30, 2020 was USD 2.17 B, a 15.87% change year over year.
Competitors
Illumina, Inc.
USD 96.14
ILMN
-1.79
-1.83%
Revvity, Inc.
USD 93.26
RVTY
-2.32
-2.43%
Syngene International Limited
USD 7.63
SYNGENE.NS
-0.16
-2.05%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.46
002317.SZ
-0.01
-0.44%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 5.01
688321.SS
+0.13
2.73%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
RELX Plc
USD 53.04
REL.L
-0.48
-0.90%
Key Data
| Date | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) | Selling, General, and Administrative Expenses (SG&A) |
|---|
Competitors
Illumina, Inc.
USD 96.14
ILMN
-1.79
-1.83%
Revvity, Inc.
USD 93.26
RVTY
-2.32
-2.43%
Syngene International Limited
USD 7.63
SYNGENE.NS
-0.16
-2.05%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.46
002317.SZ
-0.01
-0.44%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 5.01
688321.SS
+0.13
2.73%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
RELX Plc
USD 53.04
REL.L
-0.48
-0.90%